{"rows":[{"id":4197,"title":"Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.","authors":"Husein A, Traylor M, Vest MF, Wood BJ, Brogan M, Thomas A, McNeil S, Bhuiyan MAN, Hendricks P, Kelly JR, Gribben A, Al-Qahtani MM, Keys K, Edinoff AN, Patterson JC, Murnane KS","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251381806","pubmed_id":"42539773","openalex_id":"https://openalex.org/W7117566828","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-09-08 01:20:06","bibtex":null,"source_record_id":"PMID:42539773","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539773","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","doi":"10.1177/28314425251381806","pmid":"42539773","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4190,"title":"A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.","authors":"Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251387655","pubmed_id":"42539824","openalex_id":"https://openalex.org/W7117646156","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-09-08 01:20:06","bibtex":null,"source_record_id":"PMID:42539824","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539824","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","doi":"10.1177/28314425251387655","pmid":"42539824","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3730,"title":"A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.","authors":"Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-03-01","publication_year":2023,"doi":"10.1089/psymed.2022.0002","pubmed_id":"37337526","openalex_id":"https://openalex.org/W4307481727","source_url":"https://pubmed.ncbi.nlm.nih.gov/37337526/","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 11:08:42","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:37337526","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37337526/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37337526","source_url":"https://pubmed.ncbi.nlm.nih.gov/37337526/","doi":"10.1089/psymed.2022.0002","pmid":"37337526","publication_date":"2023-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1990,"title":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.","authors":"Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251404460","pubmed_id":"42539893","openalex_id":"https://openalex.org/W7116873484","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-09-08 01:20:06","bibtex":null,"source_record_id":"PMID:42539893","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539893","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","doi":"10.1177/28314425251404460","pmid":"42539893","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1534,"title":"A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.","authors":"Hibicke M, Kramer HM, Nichols CD","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-03-01","publication_year":2023,"doi":"10.1089/psymed.2022.0012","pubmed_id":"40047006","openalex_id":"https://openalex.org/W4323041020","source_url":"https://pubmed.ncbi.nlm.nih.gov/40047006/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Adolescents","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:40047006","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40047006/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40047006","source_url":"https://pubmed.ncbi.nlm.nih.gov/40047006/","doi":"10.1089/psymed.2022.0012","pmid":"40047006","publication_date":"2023-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1533,"title":"Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.","authors":"Aday JS, Skiles Z, Eaton N, Fredenburg L, Pleet M, Mantia J, Bradley ER, Fernandes-Osterhold G, Woolley JD","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-03-01","publication_year":2023,"doi":"10.1089/psymed.2022.0004","pubmed_id":"40047007","openalex_id":"https://openalex.org/W4321016287","source_url":"https://pubmed.ncbi.nlm.nih.gov/40047007/","substance_tags":"psilocybin","topic_tags":"Depression,Spirituality,Clinical Trial,Review Article,Observational Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:40047007","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40047007/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40047007","source_url":"https://pubmed.ncbi.nlm.nih.gov/40047007/","doi":"10.1089/psymed.2022.0004","pmid":"40047007","publication_date":"2023-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1467,"title":"The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs.","authors":"Lake S, Lucas P","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-06-01","publication_year":2023,"doi":"10.1089/psymed.2023.0002","pubmed_id":"40046727","openalex_id":"https://openalex.org/W4366580975","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046727/","substance_tags":"psilocybin","topic_tags":"Addiction,Wellbeing,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:15","bibtex":null,"source_record_id":"PMID:40046727","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40046727/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40046727","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046727/","doi":"10.1089/psymed.2023.0002","pmid":"40046727","publication_date":"2023-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1466,"title":"Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.","authors":"Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-06-01","publication_year":2023,"doi":"10.1089/psymed.2022.0011","pubmed_id":"40046728","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40046728/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Spirituality,Clinical Trial,Review Article,Cancer Patients,Safety,Inflammation","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:15","bibtex":null,"source_record_id":"PMID:40046728","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40046728/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40046728","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046728/","doi":"10.1089/psymed.2022.0011","pmid":"40046728","publication_date":"2023-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1384,"title":"Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.","authors":"Miller M, Rosa WE, Doerner Rinaldi A, Addicott K, Spence D, Beaussant Y","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-09-01","publication_year":2023,"doi":"10.1089/psymed.2022.0009","pubmed_id":"37753521","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37753521/","substance_tags":"psilocybin","topic_tags":"End-of-Life Distress,Spirituality","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:13","bibtex":null,"source_record_id":"PMID:37753521","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37753521/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37753521","source_url":"https://pubmed.ncbi.nlm.nih.gov/37753521/","doi":"10.1089/psymed.2022.0009","pmid":"37753521","publication_date":"2023-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1376,"title":"Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?","authors":"Pagán AF, Lex C, Soares JC, Meyer TD","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-09-01","publication_year":2023,"doi":"10.1089/psymed.2023.0022","pubmed_id":"40046569","openalex_id":"https://openalex.org/W4385987387","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046569/","substance_tags":"psilocybin","topic_tags":"Depression,Observational Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:40046569","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40046569/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40046569","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046569/","doi":"10.1089/psymed.2023.0022","pmid":"40046569","publication_date":"2023-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1375,"title":"Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.","authors":"Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-09-01","publication_year":2023,"doi":"10.1089/psymed.2023.0030","pubmed_id":"40046570","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40046570/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Wellbeing,Resilience,Mystical Experience,Clinical Trial,Observational Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:40046570","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40046570/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40046570","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046570/","doi":"10.1089/psymed.2023.0030","pmid":"40046570","publication_date":"2023-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1315,"title":"Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.","authors":"Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-12-01","publication_year":2023,"doi":"10.1089/psymed.2023.0035","pubmed_id":"38152462","openalex_id":"https://openalex.org/W4386285211","source_url":"https://pubmed.ncbi.nlm.nih.gov/38152462/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Consciousness,Wellbeing,Spirituality,Healthy Volunteers,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:38152462","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38152462/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38152462","source_url":"https://pubmed.ncbi.nlm.nih.gov/38152462/","doi":"10.1089/psymed.2023.0035","pmid":"38152462","publication_date":"2023-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1309,"title":"Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.","authors":"Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD, Miklowitz DJ","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-12-01","publication_year":2023,"doi":"10.1089/psymed.2023.0018","pubmed_id":"40046861","openalex_id":"https://openalex.org/W4386469528","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046861/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:40046861","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40046861/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40046861","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046861/","doi":"10.1089/psymed.2023.0018","pmid":"40046861","publication_date":"2023-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1308,"title":"A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.","authors":"Brennan W, Kelman AR, Belser AB","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-12-01","publication_year":2023,"doi":"10.1089/psymed.2023.0007","pubmed_id":"40046864","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40046864/","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Systematic Review,Review Article,Safety","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:40046864","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40046864/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40046864","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046864/","doi":"10.1089/psymed.2023.0007","pmid":"40046864","publication_date":"2023-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1307,"title":"Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings.","authors":"Nicholas CR, Horton DM, Malicki J, Baltes A, Hutson PR, Brown RT","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-12-01","publication_year":2023,"doi":"10.1089/psymed.2023.0012","pubmed_id":"40046866","openalex_id":"https://openalex.org/W4389304198","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046866/","substance_tags":"psilocybin","topic_tags":"Addiction,Safety,Adverse Events,Drug Interactions","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:40046866","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40046866/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40046866","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046866/","doi":"10.1089/psymed.2023.0012","pmid":"40046866","publication_date":"2023-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1202,"title":"The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.","authors":"Strickland JC, Garcia-Romeu A, Johnson MW","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2024-03-01","publication_year":2024,"doi":"10.1089/psymed.2023.0046","pubmed_id":"40051759","openalex_id":"https://openalex.org/W4392242862","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051759/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mystical Experience,Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:40051759","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40051759/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40051759","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051759/","doi":"10.1089/psymed.2023.0046","pmid":"40051759","publication_date":"2024-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1201,"title":"American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.","authors":"Barnett BS, Arakelian M, Beebe D, Ontko J, Riegal C, Siu WO, Weleff J, Pope HG","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2024-03-01","publication_year":2024,"doi":"10.1089/psymed.2023.0036","pubmed_id":"40051760","openalex_id":"https://openalex.org/W4386824127","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051760/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:40051760","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40051760/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40051760","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051760/","doi":"10.1089/psymed.2023.0036","pmid":"40051760","publication_date":"2024-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1200,"title":"Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic.","authors":"Hibicke M, Billac G, Nichols CD","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2024-03-01","publication_year":2024,"doi":"10.1089/psymed.2023.0037","pubmed_id":"40051761","openalex_id":"https://openalex.org/W4392231460","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051761/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Longevity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:40051761","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40051761/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40051761","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051761/","doi":"10.1089/psymed.2023.0037","pmid":"40051761","publication_date":"2024-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1106,"title":"A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?","authors":"Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2024-06-01","publication_year":2024,"doi":"10.1089/psymed.2023.0051","pubmed_id":"40051581","openalex_id":"https://openalex.org/W4392242849","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051581/","substance_tags":"psilocybin","topic_tags":"Aging,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:40051581","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40051581/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40051581","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051581/","doi":"10.1089/psymed.2023.0051","pmid":"40051581","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1105,"title":"Impact of Psilocybin on Peripheral Cytokine Production.","authors":"DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2024-06-01","publication_year":2024,"doi":"10.1089/psymed.2023.0039","pubmed_id":"40051582","openalex_id":"https://openalex.org/W4392242985","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051582/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:40051582","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40051582/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40051582","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051582/","doi":"10.1089/psymed.2023.0039","pmid":"40051582","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}}],"total":39,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Psychedelic medicine (New Rochelle, N.Y.)","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}